Listen to the article
The United States is facing a critical turning point in its approach to childhood vaccinations, with recent policy changes and disease outbreaks raising alarms among public health experts nationwide.
In December 2025, a CDC advisory committee led by allies of Health and Human Services Secretary Robert F. Kennedy Jr. voted to stop recommending hepatitis B vaccines for newborns, according to reporting from the Bulletin of the Atomic Scientists. This marks a significant shift from decades of established practice aimed at preventing chronic hepatitis B infections in children.
The American Academy of Pediatrics has strongly pushed back against this decision, stating that the hepatitis B vaccine given at birth significantly reduces the risk of chronic infection. According to Dr. Amanda Rosen of Johns Hopkins Bloomberg School of Public Health, “Hepatitis B vaccination is an essential safety net for newborns,” providing protection at a critical period when they are most vulnerable to developing chronic infection.
Medical professionals have expressed concern that the CDC’s testing recommendations for pregnant women are insufficient. As CNN reported, some doctors warn that hepatitis B screening during pregnancy alone will not catch all cases that could potentially lead to infant infection. A study published in November 2025 on medRxiv by researchers Hall, Gounder, Bradley, and Nelson estimated significant economic costs associated with delaying the infant hepatitis B vaccination schedule.
This policy shift comes amid broader changes to the childhood vaccination landscape. In January 2026, NPR reported that health officials had reduced the number of vaccines recommended for all children. More concerning to many public health experts, in November 2025, the CDC revived debunked claims linking childhood vaccines with autism, a position that contradicts decades of scientific evidence.
The impact of these policy changes is becoming increasingly apparent. According to KFF (formerly Kaiser Family Foundation), kindergarten routine vaccination rates have continued to decline throughout 2025. The CDC’s own data shows a troubling downward trend in vaccination coverage among kindergarteners, with increasing numbers of exemptions.
Measles, a disease once declared eliminated in the United States, has made a dramatic resurgence. A severe outbreak in South Carolina reached 789 cases by January 2026, surpassing an earlier outbreak in Texas, according to NBC News. The Washington Post reported that South Carolina’s outbreak raises significant concerns for the entire country, as vaccine hesitancy grows and vaccination rates decline.
The Pan American Health Organization has expressed concern about the United States’ measles elimination status, which had been a point of pride in American public health achievements for years.
These developments contrast sharply with earlier CDC reporting from 2024, which claimed routine childhood immunizations had saved 1.1 million lives between 1994 and 2023. This report has been contested by vaccine skeptics affiliated with Children’s Health Defense, an organization founded by Kennedy.
The economic impact of these disease outbreaks is substantial. Research published on medRxiv in October 2025 by Sriudomporn and Patenaude quantified the costs of measles outbreaks in the U.S., showing how expenses increase dramatically as outbreaks grow in size.
Vaccine misinformation appears to be playing a significant role in these trends. KFF reported in September 2024 that vaccine misinformation was spreading as children headed back to school. A 2021 study in Nature Human Behavior by Loomba et al. demonstrated how exposure to vaccine misinformation significantly reduces vaccination intent.
As the U.S. continues to grapple with these challenges, public health experts are urging a return to evidence-based vaccination policies. They point to historical successes like the eradication of smallpox and near-elimination of many childhood diseases as proof of vaccines’ importance in protecting public health.
The current trajectory threatens to reverse decades of progress in preventing childhood diseases, with potentially far-reaching consequences for public health and healthcare costs across the nation.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
11 Comments
This is a troubling development. Undermining childhood vaccination programs poses serious risks, both to individual and community health. The economic costs of outbreaks are just one concerning consequence.
Vaccine hesitancy is a complex issue, but it’s clear that the economic costs of outbreaks can be severe. Public health officials need to find ways to counter misinformation and rebuild trust in vaccination programs.
It’s concerning to see the CDC moving away from established vaccination guidelines, especially for newborns. Hepatitis B can have lifelong consequences, so protecting infants should be a top priority.
I agree, the CDC’s decision is puzzling and worrying. Newborns are so vulnerable, they need this protection.
Vaccine hesitancy is a growing challenge, and the CDC’s policy shift on hepatitis B vaccination is worrying. Protecting newborns should be a top priority to prevent chronic illness and economic disruption.
Vaccines are one of our most effective public health tools. Undermining vaccination programs, even for a single disease, can have widespread consequences. I hope the CDC reconsiders this decision in light of the potential economic harm.
The economic impacts of vaccine-preventable diseases can be devastating. Policymakers need to listen to medical experts and prioritize evidence-based vaccination policies to safeguard public health and the economy.
It’s crucial that public health policy remain grounded in scientific evidence, not misinformation. Weakening childhood vaccination programs puts everyone at risk, with significant economic ramifications.
The economic impact of vaccine misinformation is a serious concern. Policymakers need to find ways to counter false narratives and rebuild trust in proven public health interventions like routine childhood vaccination.
Stopping routine hepatitis B vaccination for newborns seems like a risky and concerning decision. This vaccine is an important safeguard against a serious chronic disease. I hope the CDC reconsiders this policy change.
This is a worrying trend. Vaccine misinformation can have significant economic impacts, as we’re seeing with these measles outbreaks. Maintaining high vaccination rates is crucial for public health and the economy.